skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
WT1 Analog Peptide Vaccine (Code C64635)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: WT1 Analog Peptide Vaccine

Definition: A peptide vaccine comprised of an epitope of human Wilms tumor 1 (WT-1) with potential antineoplastic activity. WT-1, a transcription factor, is overexpressed in most types of leukemia and in some solid cancers. Vaccination with the WT-1 analog peptide vaccine may induce a cytotoxic T-lymphocyte (CTL) response against WT-1 expressing cells, resulting in cell lysis and inhibition of cancer cell proliferation.

Display Name: WT1 Analog Peptide Vaccine

Label: WT1 Analog Peptide Vaccine

NCI Thesaurus Code: C64635 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1831984  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
WT-1 vax
WT1 Analog Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 518351
PDQ Open Trial Search ID 518351 (check for NCI PDQ open clinical trial info)
UMLS CUI C1831984

Other Properties:
     Name Value (qualifiers indented underneath)
code C64635
Contributing_Source CTRP
Legacy_Concept_Name WT1_Analog_Peptide_Vaccine
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom